Figs, Inc. (FIGS)

$4.72

+0.01

(+0.21%)▲

Market is closed - opens 7 PM, 19 Apr 2024

Insights on Figs, Inc.

  • Increasing Revenue

    Revenue is up for the last 4 quarters, 120.23M → 144.91M (in $), with an average increase of 5.9% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 4 quarters, 1.90M → 10.0M (in $), with an average increase of 40.8% per quarter

  • Vs LEVI

    In the last 1 year, Levi Strauss & Co. has given 35.8% return, outperforming this stock by 63.6%

Performance

  • $4.61
    $4.77
    $4.72
    downward going graph

    2.33%

    Downside

    Day's Volatility :3.35%

    Upside

    1.05%

    downward going graph
  • $4.37
    $8.84
    $4.72
    downward going graph

    7.42%

    Downside

    52 Weeks Volatility :50.57%

    Upside

    46.61%

    downward going graph

Returns

PeriodFigs, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
-20.84%
-0.7%
0.0%
6 Months
-26.64%
6.6%
0.0%
1 Year
-27.76%
3.7%
-1.5%
3 Years
-84.31%
14.0%
-21.8%

Highlights

Market Capitalization
791.8M
Book Value
$2.22
Earnings Per Share (EPS)
0.12
PE Ratio
38.83
Wall Street Target Price
6.32
Profit Margin
4.15%
Operating Margin TTM
9.82%
Return On Assets TTM
4.9%
Return On Equity TTM
6.61%
Revenue TTM
545.6M
Revenue Per Share TTM
3.25
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
354.5M
EBITDA
37.0M
Diluted Eps TTM
0.12
Quarterly Earnings Growth YOY
1.55
EPS Estimate Current Year
0.07
EPS Estimate Next Year
0.13
EPS Estimate Current Quarter
0.02
EPS Estimate Next Quarter
0.01

Analyst Recommendation

Buy
    55%Buy
    33%Hold
    11%Sell
Based on 18 Wall street analysts offering stock ratings for Figs, Inc.(by analysts ranked 0 to 5 stars)
Based on 18 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
10
10
Hold
6
6
6
Sell
2
2
2

Analyst Forecast

What analysts predicted

Upside of 33.9%

Current $4.72
Target $6.32

Company Financials

FY19Y/Y Change
Revenue
110.5M
-
Net Income
572.0K
-
Net Profit Margin
0.52%
-
FY20Y/Y Change
Revenue
263.1M
↑ 138.12%
Net Income
49.8M
↑ 8598.95%
Net Profit Margin
18.91%
↑ 18.39%
FY21Y/Y Change
Revenue
419.6M
↑ 59.47%
Net Income
-9.6M
↓ 119.2%
Net Profit Margin
-2.28%
↓ 21.19%
FY22Y/Y Change
Revenue
505.8M
↑ 20.55%
Net Income
21.2M
↓ 321.7%
Net Profit Margin
4.19%
↑ 6.47%
FY23Y/Y Change
Revenue
545.6M
↑ 7.87%
Net Income
22.6M
↑ 6.85%
Net Profit Margin
4.15%
↓ 0.04%
Q3 FY22Q/Q Change
Revenue
128.6M
↑ 5.19%
Net Income
4.0M
↓ 16.65%
Net Profit Margin
3.14%
↓ 0.83%
Q4 FY22Q/Q Change
Revenue
144.9M
↑ 12.68%
Net Income
3.4M
↓ 16.15%
Net Profit Margin
2.34%
↓ 0.8%
Q1 FY23Q/Q Change
Revenue
120.2M
↓ 17.02%
Net Income
1.9M
↓ 43.7%
Net Profit Margin
1.59%
↓ 0.75%
Q2 FY23Q/Q Change
Revenue
138.1M
↑ 14.89%
Net Income
4.6M
↑ 140.02%
Net Profit Margin
3.32%
↑ 1.73%
Q3 FY23Q/Q Change
Revenue
142.4M
↑ 3.06%
Net Income
6.1M
↑ 34.13%
Net Profit Margin
4.32%
↑ 1.0%
Q4 FY23Q/Q Change
Revenue
144.9M
↑ 1.79%
Net Income
10.0M
↑ 62.71%
Net Profit Margin
6.9%
↑ 2.58%
FY19Y/Y Change
Total Assets
62.6M
-
Total Liabilities
23.8M
-
FY20Y/Y Change
Total Assets
133.9M
↑ 113.83%
Total Liabilities
36.2M
↑ 52.11%
FY21Y/Y Change
Total Assets
311.8M
↑ 132.9%
Total Liabilities
66.2M
↑ 82.92%
FY22Y/Y Change
Total Assets
395.1M
↑ 26.72%
Total Liabilities
87.3M
↑ 31.95%
FY23Y/Y Change
Total Assets
473.2M
↑ 19.78%
Total Liabilities
96.4M
↑ 10.35%
Q3 FY22Q/Q Change
Total Assets
385.7M
↑ 9.05%
Total Liabilities
93.2M
↑ 23.43%
Q4 FY22Q/Q Change
Total Assets
395.1M
↑ 2.44%
Total Liabilities
87.3M
↓ 6.32%
Q1 FY23Q/Q Change
Total Assets
388.1M
↓ 1.76%
Total Liabilities
67.9M
↓ 22.23%
Q2 FY23Q/Q Change
Total Assets
411.0M
↑ 5.9%
Total Liabilities
74.1M
↑ 9.1%
Q3 FY23Q/Q Change
Total Assets
441.8M
↑ 7.49%
Total Liabilities
86.6M
↑ 16.86%
Q4 FY23Q/Q Change
Total Assets
473.2M
↑ 7.11%
Total Liabilities
96.4M
↑ 11.29%
FY19Y/Y Change
Operating Cash Flow
6.5M
-
Investing Cash Flow
-4.8M
-
Financing Cash Flow
14.0M
-
FY20Y/Y Change
Operating Cash Flow
21.7M
↑ 233.0%
Investing Cash Flow
-2.3M
↓ 52.49%
Financing Cash Flow
294.0K
↓ 97.9%
FY21Y/Y Change
Operating Cash Flow
66.4M
↑ 205.49%
Investing Cash Flow
-2.7M
↑ 19.89%
Financing Cash Flow
75.6M
↑ 25604.76%
FY22Y/Y Change
Operating Cash Flow
-35.3M
↓ 153.18%
Investing Cash Flow
-5.8M
↑ 115.63%
Financing Cash Flow
3.5M
↓ 95.34%
Q3 FY22Q/Q Change
Operating Cash Flow
-13.3M
↓ 27.93%
Investing Cash Flow
-2.5M
↑ 35.75%
Financing Cash Flow
1.2M
↑ 3.08%
Q4 FY22Q/Q Change
Operating Cash Flow
4.6M
↓ 134.11%
Investing Cash Flow
-1.1M
↓ 56.82%
Financing Cash Flow
733.0K
↓ 40.74%
Q1 FY23Q/Q Change
Operating Cash Flow
-2.9M
↓ 163.29%
Investing Cash Flow
-772.0K
↓ 29.3%
Financing Cash Flow
-245.0K
↓ 133.42%
Q2 FY23Q/Q Change
Operating Cash Flow
29.4M
↓ 1120.51%
Investing Cash Flow
-39.2M
↑ 4975.65%
Financing Cash Flow
636.0K
↓ 359.59%
Q3 FY23Q/Q Change
Operating Cash Flow
54.1M
↑ 84.1%
Investing Cash Flow
-18.0M
↓ 53.98%
Financing Cash Flow
126.0K
↓ 80.19%

Technicals Summary

Sell

Neutral

Buy

Figs, Inc. is currently in a neutral trading position according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Figs, Inc.
Figs, Inc.
-4.85%
-26.64%
-27.76%
-84.31%
-84.31%
Gildan Activewear Inc
Gildan Activewear Inc
4.17%
19.52%
8.84%
6.57%
-5.32%
Ralph Lauren Corp.
Ralph Lauren Corp.
-12.97%
36.92%
35.69%
30.34%
21.47%
V.f. Corporation
V.f. Corporation
-14.87%
-34.42%
-46.22%
-85.41%
-86.42%
Levi Strauss & Co.
Levi Strauss & Co.
13.02%
41.22%
35.83%
-26.92%
-13.16%
Pvh Corp.
Pvh Corp.
-17.9%
41.26%
22.08%
1.75%
-20.01%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Figs, Inc.
Figs, Inc.
38.83
38.83
NA
0.07
0.07
0.05
NA
2.22
Gildan Activewear Inc
Gildan Activewear Inc
11.87
11.87
4.39
2.95
0.28
0.1
0.02
11.52
Ralph Lauren Corp.
Ralph Lauren Corp.
18.24
18.24
1.15
10.26
0.23
0.07
0.02
40.25
V.f. Corporation
V.f. Corporation
56.33
NA
0.14
1.08
-0.28
0.04
0.03
5.43
Levi Strauss & Co.
Levi Strauss & Co.
68.03
68.03
NA
1.27
0.06
0.05
0.02
4.97
Pvh Corp.
Pvh Corp.
10.0
10.0
0.21
10.48
0.13
0.05
0.0
88.82
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Figs, Inc.
Figs, Inc.
Buy
$791.8M
-84.31%
38.83
4.15%
Gildan Activewear Inc
Gildan Activewear Inc
Buy
$6.1B
-5.32%
11.87
16.7%
Ralph Lauren Corp.
Ralph Lauren Corp.
Buy
$10.2B
21.47%
18.24
8.9%
V.f. Corporation
V.f. Corporation
Hold
$4.9B
-86.42%
56.33
-7.07%
Levi Strauss & Co.
Levi Strauss & Co.
Buy
$8.1B
-13.16%
68.03
2.06%
Pvh Corp.
Pvh Corp.
Buy
$6.2B
-20.01%
10.0
7.2%

Institutional Holdings

  • BAMCO Inc

    14.86%

  • Vanguard Group Inc

    7.30%

  • BlackRock Inc

    6.06%

  • T. Rowe Price Investment Management,Inc.

    5.61%

  • Capital Research & Mgmt Co - Division 3

    5.05%

  • Ameriprise Financial Inc

    3.56%

Company Information

figs is revolutionizing the antiquated $10 billion medical apparel industry through its use of ridiculously soft and technical fabrics that are tailored to perfection. figs medical apparel is anti-microbial, wrinkle resistant, stain repellent, lint free and utilizes four way stretch. through its customer-centric, vertically integrated e-commerce platform, figs has transformed the way medical professionals shop. through its threads for threads initiative, for every set of scrubs sold, figs gives a set to a healthcare provider in need. the company has raised over $10 million in capital from a great group of tech investors including campfire capital, jh partners, mohr davidow ventures, irving place capital, raptor ventures, karlin ventures, riverwood capital, 500 startups, suffolk equity partners, the milken family, will smith, peter morton, steve tisch, and john fisher.

Organization
Figs, Inc.
Employees
343
CEO
Ms. Heather L. Hasson
Industry
Services

Discover More

FAQs